Efeitos adversos associados a uso de contraceptivos orais em discentes / Adverse effects associated with students' use of oral contraceptives

Objetivos: Investigar o número de mulheres, as causas que levam a fazer o uso e descrever os efeitos adversos mais comuns associados ao uso de contraceptivos orais de forma contínua. Métodos: Trata-se de estudo observacional, transversal ou de prevalência e quantitativo. A pesquisa teve população de 832 alunas do curso de Direito dos turnos matutino, vespertino e noturno, no período de agosto a setembro, tendo como amostra 248 participantes para esse estudo. O questionário versou sobre o uso de anticoncepcionais, o perfil das usuárias e os possíveis efeitos adversos observados ao longo do uso. Resultados: A prevalência de uso dos contraceptivos orais foi de 42,3%, justificada principalmente pelo desejo de evitar a concepção (42,9%), regular os níveis hormonais (25,7%) e tratar acne (15,2%). Cerca de 63,8% relataram que já sentiram algum desconforto associado ao uso destes medicamentos, sendo os mais frequentes aumento de peso corporal (32,4%), alterações de humor (24,3%), dor nas mamas (13,5%), cefaleia (4,1%), dor abdominal (2,7%). Conclusão: A prevalência de efeitos adversos decorrentes do uso contínuo de contraceptivos orais é alta, evidenciando-se a necessidade de conscientizar as usuárias a buscarem profissionais habilitados, para que elas façam uso do anticoncepcional mais adequado, minimizando o desconforto advindo dos efeitos adversos.

Objectives: To investigate the number of women, the causes that lead to making use, and to describe the most common adverse effects associated with oral contraceptive continuous use. Methods: This is an observational, cross-sectional, or prevalence and quantitative study. The research had a population of 832 students of the law course of the morning, afternoon and evening shifts, from August to September, with a sample of 248 participants for this study. The questionnaire was about contraceptive use, users' profile, and possible adverse effects observed during use. Results: The prevalence of oral contraceptive use was 42.3%, mainly explained by the desire to avoid conception (42.9%), regulate hormone levels (25.7%), and to treat acne (15.2%). About 63.8% reported already having some discomfort associated with the use of these medications, with the most frequent being body weight gain (32.4%), mood swings (24.3%), breast pain (13.5%), headache (4.1%), abdominal pain (2.7%). Conclusion: The prevalence of adverse effects resulting from the continued use of oral contraceptives is high, so there is a need to guide users to seek qualified professionals so that they make use of the most appropriate contraceptive, minimizing the discomfort arising from adverse effects.

Efectos adversos del implante anticonceptivo subdérmico en adolescentes / Adverse effects of the subdermal contraceptive implant in adolescents

Introducción: Los anticonceptivos subdérmicos deben ser seguros, con efectos colaterales mínimos, reversibles y de larga duración, sin embargo, se ha observado que ocasionan efectos adversos, fundamentalmente en los primeros meses de su uso. Objetivos: Describir efectos adversos, junto a antecedentes personales en adolescentes a quienes se realizó implante anticonceptivo subdérmico. Métodos: Se realizó un estudio descriptivo en 120 adolescentes a las que se les colocó implante subdérmico como método anticonceptivo. Fueron estudiadas las variables efectos adversos, edad y antecedente obstétrico. Resultados: El 36,6 por ciento de las pacientes tenía antecedentes de abortos provocados, y el 5 por ciento era menor de 15 años. Los efectos adversos más frecuentes fueron el aumento de peso (23,3 por ciento a los 6 meses y 21,6 por ciento al año), la cefalea (18,3 por ciento a los 6 meses y 8,3 por ciento al año) y la mastalgia (12,5 por ciento a los 6 meses y 15 por ciento al año). En el patrón de sangrado, se presentaron, sangrado infrecuente (36 por ciento a los 6 meses y 43,3 por ciento al año) y amenorrea (27,5 por ciento a los 6 meses y 35 por ciento al año). Conclusiones: Más de un tercio de las pacientes tenían abortos previos; los efectos adversos más frecuentes fueron: aumento de peso, cefalea y mastalgia, tanto a los 6 meses como al año y en el patrón de sangrado, el sangrado infrecuente y la amenorrea(AU)

Introduction: Subdermal contraceptives must be safe, with minimal side effects, reversible and long lasting, however, it has been observed that they cause adverse effects, mainly in the first months of its use. Objectives: To describe adverse effects, together with personal history in adolescents who underwent a subdermal contraceptive implant. Methods: A descriptive study was conducted in 120 adolescents who were placed as a subdermal implant as a contraceptive method. The variables adverse effects, age and obstetric history were studied. Results: 36.6 percent of the patients had a history of induced abortions, and 5 percent were younger than 15 years. The most frequent adverse effects were weight gain (23.3 percent at 6 months and 21.6 percent per year), headache (18.3 percent at 6 months and 8.3 percent per year) and mastalgia (12.5 percent at 6 months and 15 percent at year). In the pattern of bleeding, infrequent bleeding occurred (36 percent at 6 months and 43.3 percent per year) and amenorrhea (27.5 percent at 6 months and 35 percent per year). Conclusions: More than a third of the patients had previous abortions; The most frequent adverse effects were: weight gain, headache and mastalgia, both at 6 months and 1 year and in the pattern of bleeding, infrequent bleeding and amenorrhea(AU)